Brief: Viracta Therapeutics Inc Received A Written Notice From Nasdaq Informing Co That It Has Regained Compliance With Nasdaq's Listing Rule
April 9 (Reuters) - Viracta Therapeutics Inc VIRX.O :
* VIRACTA THERAPEUTICS INC - RECEIVED A WRITTEN NOTICE FROM
NASDAQ INFORMING CO THAT IT HAS REGAINED COMPLIANCE WITH
NASDAQ'S LISTING RULE
Source text for Eikon: [ID:https://bitly.ws/3hKNT]
Further company coverage: VIRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update